So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.
Editor's note · Context
Hyde-Smith emphasizes the legal implications of FDA's actions over safety concerns.
Share
More from Cindy Hyde-Smith
As Ranking Member of the Subcommittee, I am just pleased to be a part of things like this, to ensure that the two percent of us who feed the other 98 percent, that we continue to grow.
this is an incredibly special week for pro-life Americans. We have welcomed back a life-affirming administration with the second inauguration of President Donald Trump. Both Chambers of Congress are united in our pursuit of commonsense…
as if in legislation session, notwithstanding rule XXII, I ask unanimous consent that the Committee on the Judiciary be discharged from further consideration and the Senate now proceed to S. Res. 733. The clerk will report the resolution…
I am just pleased to be a part of things like this, to ensure that the two percent of us who feed the other 98 percent, that we continue to grow.





